Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Neuroleptic”

Showing 20 of 0 results

Large-scale testing (Phase 3)Study completedNCT00517387
What this trial is testing

The Effects of Quetiapine XR on Cognition, Mood and Anxiety Symptoms in SSRI-Resistant Unipolar Depression

Who this might be right for
Unipolar Depression
University of British Columbia 64
Not applicableStudy completedNCT01280396
What this trial is testing

Metabolic Side-effects for Second-generation Antipsychotics

Who this might be right for
Mental Disorders
The University of Hong Kong 241
Large-scale testing (Phase 3)Study completedNCT00202280
What this trial is testing

Efficacy of Treating First Episode Psychosis With Folic Acid,B12 and B6 in Addition to Antipsychotic Medication

Who this might be right for
First Episode Psychosis
Melbourne Health 120
Post-approval studies (Phase 4)WithdrawnNCT02286206
What this trial is testing

Study of the Effect of Dosing on Clozapine Levels

Who this might be right for
Psychotic DisordersSchizophrenia
University of British Columbia
Not applicableEnded earlyNCT01621737
What this trial is testing

Antipsychotic Effects of Oxytocin

Who this might be right for
Schizophrenia
University of California, San Diego 42
Not applicableWithdrawnNCT01724372
What this trial is testing

The Role of Antidepressants or Antipsychotics in Preventing Psychosis

Who this might be right for
Psychotic Disorder
St. Luke's-Roosevelt Hospital Center
Not applicableStudy completedNCT00809731
What this trial is testing

Observational Study to Evaluate Efficacy and Remission Status for Schizophrenia Patients Under Atypical Treatment

Who this might be right for
Schizophrenia
AstraZeneca 490
Not applicableStudy completedNCT01154829
What this trial is testing

Pan European Collaboration on Antipsychotic Naive Schizophrenia (PECANS)

Who this might be right for
Schizophrenia
University of Copenhagen 136
Not applicableLooking for participantsNCT06729671
What this trial is testing

A Probiotic Strategy for Antipsychotic-induced Metabolic Dysfunction

Who this might be right for
Psychosis
University College Cork 70
Post-approval studies (Phase 4)Study completedNCT00545467
What this trial is testing

Evaluation of the Strategies of Switching Schizophrenia Patients to Aripiprazole From Other Antipsychotic Agents

Who this might be right for
DSM-IV SchizophreniaSchizoaffective Disorder
National Taiwan University Hospital 79
Not applicableStudy completedNCT02897167
What this trial is testing

Study of the Activation of Proinflammatory Pathways of Toll-like Receptors in Schizophrenia Patients

Who this might be right for
SchizophreniaMental DisordersPsychotic Disorders
Fundación Marques de Valdecilla 150
Testing effectiveness (Phase 2)Study completedNCT00862992
What this trial is testing

Safety, Pharmacokinetics and Efficacy Study of MP-214 in Patients With Schizophrenia

Who this might be right for
Schizophrenia
Tanabe Pharma Corporation 34
Not applicableStudy completedNCT01447082
What this trial is testing

General Practice Research Database Seroquel XR Safety Study

Who this might be right for
SchizophreniaMajor Depressive DisorderBipolar Disorder
AstraZeneca 37,372
Testing effectiveness (Phase 2)Study completedNCT06179108
What this trial is testing

Randomized, Double-blinded, Placebo-controlled, Evaluating the Treatment With LB-102 in Patients With Acute Schizophrenia

Who this might be right for
Schizophrenia
LB Pharmaceuticals Inc. 359
Large-scale testing (Phase 3)Study completedNCT02013609
What this trial is testing

Brexpiprazole (OPC-34712) as an Adjunctive Treatment in Active Adults, 18 to 35 Years Old, With Major Depressive Disorder Who Are in a School or Work Environment

Who this might be right for
MDD
Otsuka Pharmaceutical Development & Commercialization, Inc. 48
Large-scale testing (Phase 3)Study completedNCT00253149
What this trial is testing

The Effectiveness and Safety of Risperidone as add-on Therapy to Mood Stabilizers in the Treatment of Manic Episodes Associated With Bipolar Disorder

Who this might be right for
Bipolar DisordersManic Disorder
Johnson & Johnson Pharmaceutical Research & Development, L.L.C. 158
Not applicableStudy completedNCT03451734
What this trial is testing

Optimizing and Individualizing the Pharmacological Treatment of First-episode Schizophrenic Patients

Who this might be right for
SchizophreniaMetabolic Syndrome
Central South University 2,000
Large-scale testing (Phase 3)Study completedNCT06067984
What this trial is testing

An Extension Study of a Second Course of a Digital Therapeutic for the Treatment of Experiential Negative Symptoms of Schizophrenia

Who this might be right for
SchizophreniaNegative Symptoms in Schizophrenia
Click Therapeutics, Inc. 73
Post-approval studies (Phase 4)Study completedNCT00304616
What this trial is testing

SWitching to Abilify Trial (SWAT)

Who this might be right for
Schizophrenia
Korea Otsuka Pharmaceutical Co., Ltd. 500
Large-scale testing (Phase 3)Study completedNCT00246285
What this trial is testing

The Effectiveness and Safety of Risperidone in the Treatment of Adolescents With Schizophrenia

Who this might be right for
SchizophreniaPsychotic Disorders
Johnson & Johnson Pharmaceutical Research & Development, L.L.C. 381
Next Page

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation